Recommended Dose of Ofloxacin + Ornidazole for Adults
For adult patients, the standard dose of ofloxacin + ornidazole combination is ofloxacin 200 mg + ornidazole 500 mg administered twice daily (every 12 hours) for 5 days, typically used for gastrointestinal infections including diarrhea and dysentery 1, 2.
Dosing Details
Standard Adult Dosing
- Ofloxacin: 200-400 mg every 12 hours orally
- Ornidazole: 500 mg (when combined with ofloxacin)
- Frequency: Twice daily (every 12 hours)
- Duration: Typically 5 days for gastrointestinal infections 2
The FDA-approved dosing for ofloxacin alone varies by indication 1:
- Uncomplicated cystitis: 200 mg every 12 hours for 3-7 days
- Complicated UTIs: 200 mg every 12 hours for 10 days
- Pelvic inflammatory disease: 400 mg every 12 hours for 10-14 days (with metronidazole)
- Gonorrhea: 400 mg single dose
Clinical Context for Combination Therapy
When ofloxacin is combined with ornidazole (as in the fixed-dose combination), the typical indication is for mixed aerobic-anaerobic gastrointestinal infections. A clinical study of 256 patients demonstrated that ofloxacin 200 mg + ornidazole 500 mg twice daily for 5 days significantly reduced watery stools from 9.3 to 1.4 per day, with 98.43% of patients showing good to excellent efficacy 2.
For pelvic inflammatory disease specifically, CDC guidelines recommend ofloxacin 400 mg every 12 hours PLUS metronidazole 500 mg every 8-12 hours for 14 days 3.
Dose Adjustments
Renal Impairment
Critical adjustment required 1:
- CrCl 20-50 mL/min: Give usual dose every 24 hours (instead of every 12 hours)
- CrCl <20 mL/min: Give half the usual dose every 24 hours
Hepatic Impairment
- Maximum 400 mg per day in patients with severe liver dysfunction (cirrhosis with or without ascites) 1
Important Administration Considerations
Avoid concurrent administration with 1:
- Antacids containing calcium, magnesium, or aluminum
- Sucralfate
- Iron supplements
- Multivitamins with zinc
- Didanosine
These should be separated by at least 2 hours before or after ofloxacin administration to prevent significant reduction in absorption.
Safety Considerations
The fixed-dose combination of ofloxacin-ornidazole is not FDA-approved but is commonly used in developing countries 4. Minor adverse effects reported include nausea (7.42%), gastritis (7.14%), and metallic taste (5.85%) 2. Fixed drug eruptions have been reported with this combination 4.
Elderly patients require standard dosing unless renal function is impaired (CrCl ≤50 mL/min), in which case dose adjustment is mandatory 1.